Pakistan Reinsurance Company Limited (PSX: PAKRI)
Pakistan
· Delayed Price · Currency is PKR 15.00
-0.33 (-2.15%)
At close: Dec 24, 2024
PSX: PAKRI Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Premiums & Annuity Revenue | 10,384 | 9,323 | 7,929 | 7,226 | 6,709 | 6,905 | Upgrade
|
| Total Interest & Dividend Income | 3,169 | 2,423 | 1,540 | 1,071 | 1,043 | 748.35 | Upgrade
|
| Gain (Loss) on Sale of Investments | 421.17 | 203.3 | -39.34 | 30.51 | 105.56 | 190.02 | Upgrade
|
| Other Revenue | 482.68 | 482.68 | 217.18 | 75.58 | 74.35 | 149.06 | Upgrade
|
| Total Revenue | 14,457 | 12,432 | 9,647 | 8,403 | 7,932 | 7,993 | Upgrade
|
| Revenue Growth (YoY) | 23.90% | 28.87% | 14.81% | 5.94% | -0.76% | 28.74% | Upgrade
|
| Policy Benefits | 4,491 | 4,707 | 4,312 | 3,778 | 3,925 | 4,259 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 1,276 | 1,212 | 1,239 | 1,114 | 1,027 | 1,281 | Upgrade
|
| Selling, General & Administrative | 2,018 | 1,591 | 1,544 | 736.94 | 673.73 | 779.19 | Upgrade
|
| Provision for Bad Debts | 216.8 | 216.8 | -542.51 | 8.78 | 426.55 | 122.92 | Upgrade
|
| Other Operating Expenses | 299.81 | 335.67 | -208.73 | -148.28 | -120.83 | -44.1 | Upgrade
|
| Total Operating Expenses | 8,302 | 8,064 | 6,344 | 5,489 | 5,931 | 6,403 | Upgrade
|
| Operating Income | 6,155 | 4,369 | 3,303 | 2,914 | 2,001 | 1,590 | Upgrade
|
| Interest Expense | -6.22 | -2.35 | -2.41 | -2.46 | -2.49 | -1.47 | Upgrade
|
| Earnings From Equity Investments | 104.41 | 63.47 | 20.31 | 3.66 | 1.88 | 0.51 | Upgrade
|
| Currency Exchange Gain (Loss) | 671.62 | 671.62 | 138.24 | 66.67 | -15.3 | 603.31 | Upgrade
|
| Other Non Operating Income (Expenses) | -101 | 47.41 | 109.78 | -58.96 | -0.26 | 1.11 | Upgrade
|
| EBT Excluding Unusual Items | 6,824 | 5,149 | 3,569 | 2,923 | 1,984 | 2,193 | Upgrade
|
| Asset Writedown | 6.81 | 87.65 | - | 698.06 | - | - | Upgrade
|
| Pretax Income | 6,830 | 5,236 | 3,569 | 3,621 | 1,984 | 2,193 | Upgrade
|
| Income Tax Expense | 3,147 | 2,171 | 944.32 | 1,031 | 592.98 | 708.74 | Upgrade
|
| Net Income | 3,684 | 3,065 | 2,625 | 2,590 | 1,391 | 1,484 | Upgrade
|
| Net Income to Common | 3,684 | 3,065 | 2,625 | 2,590 | 1,391 | 1,484 | Upgrade
|
| Net Income Growth | 11.18% | 16.78% | 1.36% | 86.11% | -6.26% | 20.87% | Upgrade
|
| Shares Outstanding (Basic) | 900 | 900 | 900 | 900 | 900 | 900 | Upgrade
|
| Shares Outstanding (Diluted) | 900 | 900 | 900 | 900 | 900 | 900 | Upgrade
|
| EPS (Basic) | 4.09 | 3.41 | 2.92 | 2.88 | 1.55 | 1.65 | Upgrade
|
| EPS (Diluted) | 4.09 | 3.41 | 2.92 | 2.88 | 1.55 | 1.65 | Upgrade
|
| EPS Growth | 11.18% | 16.78% | 1.36% | 86.11% | -6.26% | 20.87% | Upgrade
|
| Free Cash Flow | -2,400 | 2,353 | 1,682 | 151.55 | 1,435 | 526.71 | Upgrade
|
| Free Cash Flow Per Share | -2.67 | 2.61 | 1.87 | 0.17 | 1.59 | 0.59 | Upgrade
|
| Dividend Per Share | 0.750 | 0.750 | 0.750 | 0.667 | 0.833 | 0.667 | Upgrade
|
| Dividend Growth | 0% | 0% | 12.49% | -19.99% | 24.99% | 0% | Upgrade
|
| Operating Margin | 42.57% | 35.14% | 34.24% | 34.68% | 25.22% | 19.89% | Upgrade
|
| Profit Margin | 25.48% | 24.66% | 27.21% | 30.82% | 17.54% | 18.57% | Upgrade
|
| Free Cash Flow Margin | -16.60% | 18.93% | 17.43% | 1.80% | 18.09% | 6.59% | Upgrade
|
| EBITDA | 6,102 | 4,417 | 3,335 | 2,920 | 2,008 | 1,598 | Upgrade
|
| EBITDA Margin | 42.21% | 35.53% | 34.56% | 34.76% | 25.31% | 19.99% | Upgrade
|
| D&A For EBITDA | -52.69 | 48.42 | 31.36 | 6.47 | 7.27 | 7.98 | Upgrade
|
| EBIT | 6,155 | 4,369 | 3,303 | 2,914 | 2,001 | 1,590 | Upgrade
|
| EBIT Margin | 42.57% | 35.14% | 34.24% | 34.68% | 25.22% | 19.89% | Upgrade
|
| Effective Tax Rate | 46.07% | 41.46% | 26.46% | 28.48% | 29.88% | 32.32% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.